The ELISA to detect anti-PEG IgG and IgM was conducted using a previously developed method.10 Briefly, the eight-arm PEG-NH2 (40 kDa, 200 μg mL–1, JenKem Technology, USA) in PBS was coated onto MaxiSorp 96-well plates (Nunc, Denmark) for 18 h at 4 °C, followed by washing with PBS four times. Plates were blocked with 5% (w/v) skim milk powder in PBS for 22 h, followed by adding serially diluted human plasma in 5% skim milk in duplicate for 1 h at 22 °C. Plates were washed with 0.1% 3-[(3-cholamidopropyl)-dimethylammonio]-1-propanesulfonate (CHAPS, Sigma-Aldrich, USA)/PBS buffer twice and PBS four times prior to addition of an HRP-conjugated antihuman IgG (Dako Agilent, USA) at 1:20,000 dilution or HRP-conjugated antihuman IgM (Jackson ImmunoResearch Laboratories, USA) at 1:10,000 for 1 h at 22 °C. Plates were washed as above and then developed using 3,3′,5,5′-tetramethylbenzidine (TMB) liquid substrate (Sigma-Aldrich, USA). The reaction was stopped with 0.16 M H2SO4 and read at 450 nm. End point titers were calculated as the reciprocal plasma dilution giving signal 2× background using a fitted curve (4-parameter log regression) and reported as a mean of duplicates. Background was detected by adding the diluted plasma samples (at a 1:10 dilution in 5% skim milk) to the non-PEG-coated wells, followed by the same ELISA procedure.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.